Dr. Özlem Akbal Dağıstan was born on January 1, 1985. She began her undergraduate studies at Istanbul University Faculty of Pharmacy in 2004 and completed her doctorate in the Department of Pharmaceutical Technology. Between 2010 and 2024, she worked as a research assistant in the same department. Starting her academic journey at a young age, Dr. Özlem Akbal Dağıstan studied at Freie Universitat Berlin as an ERASMUS student during her undergraduate program in the 2006-2007 academic year. In 2016-2017, she conducted her doctoral research at Trinity College Dublin. She also spent part of her academic career at Van Yüzüncü Yıl University. Dr. Özlem Akbal Dağıstan was pursuing a second doctorate as a PhD candiadate in Pharmacy Management at Ankara University and had earned specialized certifications in this field from Utrecht University. Dr. Özlem Akbal Dağıstan’s research focused on developing innovative pharmaceutical dosage forms for inhalation and targeted lung delivery. During the COVID-19 pandemic, she dedicated her efforts to antiviral inhalation therapies, achieving significant success with one of her projects, which successfully completed Phase 2 clinical trials. Throughout her career, Dr. Özlem Akbal Dağıstan mentored numerous students, authored 41 scientific publications, and played a pivotal role in various research projects. She was known as a visionary, determined, and selfless academician. Her untimely passing was deeply felt across both national and international academic communities. Admired for her problem-solving skills and quick, practical intelligence, Dr. Özlem Akbal Dağıstan was deeply empathetic and socially adept. She was known for fostering sincere connections with individuals from diverse backgrounds, her strong sense of human values, and her vibrant, optimistic spirit. With a profound sense of duty, coupled with her cheerful and compassionate approach to life and work, she left an inspiring legacy behind.